Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: Prior infection by EBV and other agents

British Journal of Cancer

Volumn 82, Issue 5, 2000, Pages 1117-1121

  Alexander, F E ^a   Jarrett, R F ^b   Lawrence, D ^c   Armstrong, A A ^b   Freeland, J ^b   Gokhale, D A ^d   Kane, E ^e   Taylor, G M ^d   Wright, D H ^f   Cartwright, R A ^e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Leukaemia Research Fund Virus Centre   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e Yorkshire Centre for Clinical Oncology   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Aetiology; Epstein Barr virus; Hodgkin's disease; Infectious agents; Late host exposure model

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER RISK; CHICKENPOX; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENDER; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; PERTUSSIS; PRIORITY JOURNAL; RACE; REED STERNBERG CELL; REGRESSION ANALYSIS; RISK FACTOR; RUBELLA; VIRUS INFECTION;

EID: 0034054749     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1049     Document Type: Article

References (23)

1. Armstrong AA, Weiss LM, Gallagher A, Jones DB, Krajewski AS, Angus B, Brown G, Jack AS, Wilkins BS and Onions DE (1992) Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease. Leukemia 6: 869-874
2. Carter CD, Brown TM Jn, Herbert JT and Heath CW (1977) Cancer incidence following infectious mononucleosis. Am J Epidemiol 105: 30
3. Cartwright RA, Alexander FE, McKinney PA, Ricketts TJ, Hayhoe FGJ and Clayton DGC (1990) Leukaemia and Lymphoma: An Atlas of Distribution Within Areas of England and Wales, 1984-88. Leukaemia Research Fund: London
4. Clayton D and Hills M (eds) (1993) Statistical Methods in Epidemiology. Oxford University Press: New York
5. Connelly RR and Christine BW (1974) A cohort study of cancer following infectious mononucleosis. Cancer Res 34: 1172
6. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, OGrady J, Hummel M, Preciado MV, Knecht H, Chan JKC and Claviez A (1997) Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 70: 375-382
7. Gutensohn N and Cole P (1980) Epidemiology of Hodgkin's disease. Semin Oncol 7: 92
8. Jarman B, Townsend P and Carstairs V (1991) Deprivation indices. Br J Med 303: 5 23
9. Jarrett RF, Armstrong AA and Alexander FE (1996) Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 7: S5-S10
10. Kvale G, Hoiby EA and Pedersen E (1979) Hodgkin's disease in patients with previous infectious mononucleosis. Int J Cancer 23: 593
11. Levine R, Zhu KM, Gu Y, Brann E, Hall I, Caplan L and Baum M (1998) Self-reported infectious mononucleosis and 6 cancers. A population based case-control study. Scand J Inf Dis 30: 211-214
12. Mack TM, Cozen W, Shibata DK, Weiss LM, Nathwani BN, Hernandez AM, Taylor CR, Hamilton AS, Deapen DM and Rappaport EB (1995) Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young adult form of the disease. N Engl J Med 332: 413-418
13. MacMahon M (1966) Epidemiology of Hodgkin's disease. Cancer Res 26: 1189
14. Miller RW and Beebe GW (1973) Infectious mononucleosis and the empirical risk of cancer. J Natl Cancer Inst 50: 315
15. Michels KB (1995) The origins of Hodgkin's disease. Eur J Cancer Prev 4: 379-388
16. Mueller NE (1996) Hodgkin's disease. In: Cancer Epidemiology and Prevention, 2nd edn, Schottenfield D and Fraumeni JF Jr (eds). Oxford University Press: New York
17. Mueller NE and Grufferman S (1999) Epidemiology. In: Hodgkin's Disease, Mauch P, Armitage J, Diehl V, Hoppe R and Weiss L (eds) Raven Press: New York (in press)
18. Munoz N, Davidson RJL, Witthoff B, Ericsson JE and De-The G (1978) Infectious mononucleosis and Hodgkin's disease. Int J Cancer 22: 10
19. Paffenbarger RS Jn, Wing AL and Hyde RT (1977) Characteristics in youth indicative of adult-onset Hodgkin's disease. J Natl Cancer Inst 58: 1489
20. Pallesen G, Hamilton-Dutoit SJ, Rowe M and Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337: 320-322
21. Rosdahl N, Larsen SO and Clemmenson J (1974) Hodgkin's disease in patients with infectious mononucleosis: 30 years experience. Br Med J 2: 253
22. Sleckman BG, Mauch PM, Ambinder RF, Mann R, Pinkus GS, Kadin ME, Sherburne B, PerezAtayde A, Thior I and Mueller N (1998) Correlation between EBV-status and risk factor profile in Hodgkin's disease. Cancer Epidemiol Biomark Prev 7: 1117-1121
23. Weiss LM, Stickler JG, Warnke RA, Purtilo DT and Sklar J (1987) Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 129: 86-91